z-logo
Premium
Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane
Author(s) -
PipiliSynetos Eva,
Kritikou Sosanna,
Papadimitriou Evangelia,
Athanassiadou Aglaia,
Flordellis C,
Maragoudakis M E
Publication year - 2000
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702986
Subject(s) - chorioallantoic membrane , angiogenesis , nitric oxide synthase , nitric oxide , biology , in vivo , endothelial nos , atp synthase , citrulline , nitric oxide synthase type iii , neovascularization , enzyme , medicine , endocrinology , biochemistry , chemistry , arginine , enos , cancer research , microbiology and biotechnology , amino acid
In order to elucidate further the role of nitric oxide (NO) as an endogenous antiangiogenic mediator, mRNA expression of inducible nitric oxide synthase (iNOS), enzyme activity and production of NO were determined in the chick chorioallantoic membrane (CAM), an in vivo model of angiogenesis. In this model, maximum angiogenesis is reached between days 9–12 of chick embryo development. After that period, vascular density remains constant. Inducible NO synthase (iNOS) mRNA expression, determined by reverse transcriptase polymerase chain reaction (RT–PCR), increased from the 8th day reaching a maximum (70% increase) at days 10–11. NO synthase activity, determined as citrulline formation in the presence of calcium, also increased from day 8 reaching a maximum around day 10 (100% increase). Similar results were obtained in the absence of calcium suggesting that the NOS determined was the inducible form. Nitric oxide production, determined as nitrites, increased from day 8 reaching a maximum around day 10 (64% increase) and remaining stable at day 13. Finally, the bacterial lipopolysaccharide LPS (which activates transcriptionally iNOS), inhibited dose dependently angiogenesis in the CAM. These results in connection with previous findings from this laboratory, showing that NO inhibits angiogenesis in the CAM, suggest that increases in iNOS expression, enzyme activity and NO production closely parallel the progression of angiogenesis in the CAM, thus providing an endogenous brake to control this process.British Journal of Pharmacology (2000) 129 , 207–213; doi: 10.1038/sj.bjp.0702986

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here